Skip to main content

Table 2 Differences in gametocyte carriage before and after SMC treatment

From: Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children

Measure Group p value
SMC Comparison
Percentage of gametocyte carriers before SMC treatment 7/65 (10.7%) 10/75 (13.3%) 0.64*
Percentage of gametocyte carriers after SMC treatment
 Received at least first dose of treatment 5/53 (9.4%) 9/71 (12.7%) 0.57*
 Received all 3-day doses of treatment 5/32 (15.6%) 9/71 (12.7%) 0.68*
Odds ratio comparing gametocyte carriage before vs after SMC treatment. OR (95% CI)
 Received at least first dose of treatment 0.6 (0.14–2.51)   0.48
 Received all 3-day doses of treatment 1.0 (0.20–4.95)   1.00
   0.9 (0.34–2.30) 0.80
  1. * Chi- squared test used to assess between-group difference in proportion of gametocyte carriers
  2. Conditional logistic regression used to determine within-group odds of gametocyte carriage